Business Boom for Autoscribe
News Dec 23, 2014
Autoscribe Ltd, believes that its continued growth is due in no small part to the pricing structure and configurability of its flagship Matrix Gemini LIMS. In results announced for the most recent financial year, increased turnover in the UK was also accompanied by an increase in orders of more than 30% from the US office, with both operations reporting increased profitability.
Autoscribe’s Managing Director, John Boother, said: “In a recent survey of our customers, ‘Value for money’ and ‘The ability to configure for any type of testing’ were the overwhelming reasons given for choosing our Matrix Gemini products.”
“The company has shown sustained growth over the two most recent financial years, and even more encouragingly, we are already seeing a further UK business growth of close to 30% in the current financial year,” he continued. “Not only that, our work in progress (awaiting invoicing) is also at a record high. The increases in order intake and profitability represent an excellent return following a significant period of investment, particularly in the US organization.”
“Product and pricing benefits are only part of the story, however,” he concluded. “We also understand the importance of the relationship between our sales team and our customers. The customer survey also showed that 87% of purchasers rated our sales team at 8/10 or better with more than 50% of these giving them a score of 10/10.”
The architecture of each person’s brain is unique, and differences may influence how quickly people can complete various cognitive tasks.o learn more, scientists are developing a new tool — computational models of the brain — to simulate how the structure of the brain may impact brain activity and, ultimately, human behavior.READ MORE
An artificial intelligence (AI) approach based on deep learning convolutional neural network (CNN) could identify nuanced mammographic imaging features specific for recalled but benign (false-positive) mammograms and distinguish such mammograms from those identified as malignant or negative.
2nd International Conference on Computational Biology and Bioinformatics
May 17 - May 18, 2019